Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance.
Saved in:
| Title: | Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance. |
|---|---|
| Authors: | Umehara K; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland. Electronic address: kenichi.umehara@roche.com., Harrell A; Bristol Myers Squibb, Pharmaceutical Candidate Optimisation, Lawrenceville, NJ, USA., Prakash C; DMPK/Clinical Pharmacology, Agios, Cambridge, MA, USA., Hilgendorf C; DMPK, Early Research and Development Cardiovascular, Renal and Metabolism BioPharmaceuticals RD, AstraZeneca, Gothenburg, Sweden., Ballard TE; Drug Metabolism, Pharmacokinetics and Modeling, Takeda Development Center Americas, Inc., Cambridge, MA, USA., Huth F; PK Sciences, BioMedical Research. Novartis, Basel, Switzerland., Badée J; PK Sciences, BioMedical Research. Novartis, Basel, Switzerland., Jiang L; Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals, Inc., San Diego, CA, USA., Vourvahis M; Pfizer Inc., Research and Development, New York, NY, USA., Pajkovic N; Pharmacokinetics, Dynamics, Metabolism and Bioanalytics, Merck & Co. Inc., Rahway, NJ, USA., Parrott N; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Thakkar N; GSK, 1250 S Collegeville Road, Collegeville, PA, USA., Marroum P; Clinical Pharmacology, Abbvie, Bldg AP31, 1 North Waukegan Road, North Chicago, IL, USA., Laethem R; Clinical Pharmacology & DMPK, Alkermes, 900 Winter Street, Waltham, MA, USA., Xu S; Preclinical Sciences & Translational Safety, Johnson & Johnson Innovative Medicine, Spring House, PA, USA., Chen Y; Genentech Inc., South San Francisco, CA, USA. |
| Source: | Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2026 Feb; Vol. 66, pp. 101512. Date of Electronic Publication: 2025 Dec 12. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101164773 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-0920 (Electronic) Linking ISSN: 13474367 NLM ISO Abbreviation: Drug Metab Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41494463 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Umehara+K%22">Umehara K</searchLink>; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland. Electronic address: kenichi.umehara@roche.com.<br /><searchLink fieldCode="AU" term="%22Harrell+A%22">Harrell A</searchLink>; Bristol Myers Squibb, Pharmaceutical Candidate Optimisation, Lawrenceville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Prakash+C%22">Prakash C</searchLink>; DMPK/Clinical Pharmacology, Agios, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hilgendorf+C%22">Hilgendorf C</searchLink>; DMPK, Early Research and Development Cardiovascular, Renal and Metabolism BioPharmaceuticals RD, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Ballard+TE%22">Ballard TE</searchLink>; Drug Metabolism, Pharmacokinetics and Modeling, Takeda Development Center Americas, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Huth+F%22">Huth F</searchLink>; PK Sciences, BioMedical Research. Novartis, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Badée+J%22">Badée J</searchLink>; PK Sciences, BioMedical Research. Novartis, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jiang+L%22">Jiang L</searchLink>; Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals, Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Vourvahis+M%22">Vourvahis M</searchLink>; Pfizer Inc., Research and Development, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Pajkovic+N%22">Pajkovic N</searchLink>; Pharmacokinetics, Dynamics, Metabolism and Bioanalytics, Merck & Co. Inc., Rahway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Parrott+N%22">Parrott N</searchLink>; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Thakkar+N%22">Thakkar N</searchLink>; GSK, 1250 S Collegeville Road, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Marroum+P%22">Marroum P</searchLink>; Clinical Pharmacology, Abbvie, Bldg AP31, 1 North Waukegan Road, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Laethem+R%22">Laethem R</searchLink>; Clinical Pharmacology & DMPK, Alkermes, 900 Winter Street, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Xu+S%22">Xu S</searchLink>; Preclinical Sciences & Translational Safety, Johnson & Johnson Innovative Medicine, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Genentech Inc., South San Francisco, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101164773%22">Drug metabolism and pharmacokinetics</searchLink> [Drug Metab Pharmacokinet] 2026 Feb; Vol. 66, pp. 101512. <i>Date of Electronic Publication: </i>2025 Dec 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101164773 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1880-0920 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213474367%22">13474367 </searchLink><i>NLM ISO Abbreviation: </i>Drug Metab Pharmacokinet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41494463 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.dmpk.2025.101512 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101512 Titles: – TitleFull: Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Umehara K – PersonEntity: Name: NameFull: Harrell A – PersonEntity: Name: NameFull: Prakash C – PersonEntity: Name: NameFull: Hilgendorf C – PersonEntity: Name: NameFull: Ballard TE – PersonEntity: Name: NameFull: Huth F – PersonEntity: Name: NameFull: Badée J – PersonEntity: Name: NameFull: Jiang L – PersonEntity: Name: NameFull: Vourvahis M – PersonEntity: Name: NameFull: Pajkovic N – PersonEntity: Name: NameFull: Parrott N – PersonEntity: Name: NameFull: Thakkar N – PersonEntity: Name: NameFull: Marroum P – PersonEntity: Name: NameFull: Laethem R – PersonEntity: Name: NameFull: Xu S – PersonEntity: Name: NameFull: Chen Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1880-0920 Numbering: – Type: volume Value: 66 Titles: – TitleFull: Drug metabolism and pharmacokinetics Type: main |
| ResultId | 1 |